Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: An investigation in bladder cancer by interphase FISH

Genes Chromosomes and Cancer

Volumn 25, Issue 4, 1999, Pages 376-383

  Stacey, Michael ^a   Matas, Nada ^b   Drake, Marcus ^b   Payton, Mark ^b   Fakis, Giannoulis ^b   Greenland, John ^b   Sim, Edith ^b  

^a CENTER FOR PEDIATRIC RESEARCH   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; ARYLAMINE ACETYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; BLADDER CANCER; CANCER STAGING; CHROMOSOMAL LOCALIZATION; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME DELETION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACETYLTRANSFERASES; ANEUPLOIDY; ARYLAMINE N-ACETYLTRANSFERASE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; CLONING, MOLECULAR; COSMIDS; GENETIC MARKERS; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; ISOENZYMES; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 0032784039     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199908)25:4<376::AID-GCC10>3.0.CO;2-H     Document Type: Article

References (38)

1. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. 1995a. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT11*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55:5226-5229.
2. Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC. 1995b. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55:3537-3542.
3. Bell SM, Zuo J, Myers RM, Knowles MA. 1996. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localization of the critical interval to 30 kb. Genes Chromosomes Cancer 17:108-117.
4. Brockmoller J, Kaiser R, Kerb R, Cascorbi I, Jaeger V, Roots I. 1996. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. Pharmacogenetics 6:535-545.
5. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. 1998. Mutations of mitotic check-point genes in human cancers. Nature 392:300-303.
6. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Hall DB, Higgins E, Kahn MA. 1982. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet ii:842-845.
7. Case RA, Hosker ME, McDonald DB, Pearson JT. 1954. Tumours of the urinary bladder in workmen engaged in manufacture and use of certain dyestuff intermediates in the British chemical industry. Br J Ind Med 50:389-411.
8. Emi M, Kujiwara Y, Ohata H, Tsuda H, Hirohashi S, Koike M, Miyaki M, Monden M, Nakamura Y. 1993. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 7:152-157.
9. Kujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y. 1993. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal cancer. Cancer Res. 53:1172-1174.
10. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. 1997. Molecular biology of colorectal cancer. Curr Probl Cancer 21:233-300.
11. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barrett JC, Chenevix-Trench G. 1996. Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer. Cancer Res 56:5238-5245.
12. Knowles MA, Shaw ME, Proctor AJ. 1993. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphism and microsatellite polymorphisms. Oncogene 8:1357-1364.
13. Leach RJ, Banga SS, Ben-Othame K, Chughtai S, Clarke R, Daiger SP, Kolehmainen J, Kumar S, Kuo M, Macoska J, Matas N, Naylor SL, Nunes M, O'Connell P, Pebusque MJ, Pekkel V, Porter CJ, Simons CT, Sohocki MM, Trapman J, Wells D, Westbrook C, Wood S. 1996. Report of the third international workshop on human chromosome 8 mapping 1996. Cytogenet Cell Genet 75:71-84.
14. MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R. 1996. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 35:55-65.
15. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ. 1995. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 55:5390-5395.
16. Matas N, Thygesen P, Stacey M, Risch A, Sim E. 1997. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet Cell Genet 77:290-295.
17. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, Sidransky D. 1996. Molecular detection of primary bladder cancer by microsatellite analysis. Science 271:659-662.
18. Morris JS, Carter NR, Ferguson-Smith MA, Edwards PA. 1997. Cytogenetic analysis of three breast carcinoma cell lines using reverse chromosome painting. Genes Chromosomes Cancer 20:120-139.
19. Ohata H, Emi M, Fujiwara Y, Higashino K, Nakagawa K, Futagami R, Tsuchiya E, Nakamura Y. 1993. Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes Cancer 7:85-88.
20. Olumni AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI, Jones PA. 1990. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinoma of the bladder. Cancer Res 50:7081-7083.
21. Presti JC, Reuter VE, Galan T, Fair WR, Cordon-Cardo C. 1991. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51:5405-5409.
22. Probst-Hensch NM, Haile RW, Li DS, Sakamoto GT, Louie AD, Lin BK, Frankl HD, Lee ER, Lin HJ. 1996. Lack of association between the polyadenylation polymorphism in the NAT 1 (acetyl-transferase 1) gene and colorectal adenomas. Carcinogenesis 17:2125-2129.
23. Pycha A, Mian C, Haitel A, Hofbauer J, Wiener H, Marberger M. 1997. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer. J Urol 157:2116-2119.
24. Qian J, Jenkins RB, Bostwick DG. 1997. Detection of chromosomal anomalies and c-myc amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridisation. Mod Pathol 10:1113-1119.
25. Risch A, Wallace DMA, Bathers S, Sim E. 1995. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking telated bladder cancer. Hum Mol Genetics 4:231-236.
26. Sandberg AA, Berger CS. 1994. Review of chromosome studies in urological tumours. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 151:545-560.
27. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschman R, Narayan P, Mihatsch MJ, Waldman FM. 1995. C-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 146:1131-1139.
28. Smelt VA, Mardon HJ, Sim E. 1998. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4. Pharmacol Toxicol 83:149-153.
29. Stacey M, Gallimore PH, McConville C, Taylor AMR. 1990. Rearrangement of the same chromosome regions in different SV40 transformed human skin keratinocyte lines is associated with tumourigenicity. Oncogene 5:727-739.
30. Stacey M, Thygesen P, Stanley L, Matas N, Risch A, Sim E. 1996. Arylamine N-acetyltransferase as a potential biomarker in bladder cancer: fluorescent in situ hybridisation and immunochemical studies. Biomarkers 1:55-61.
31. Stacey M, Payton M, Fakis G, Pope J, Sim E. 1998. Characterisation of arylamine N-acetyltransferase in the human urothelial cell line RT112. Pathogenesis 8:1-6.
32. Stanley LA, Coroneos E, Cuff R, Hickman D, Ward A, Sim E. 1996. Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem 44:1059-1067.
33. Takle LA, Knowles MA. 1996. Deletion mapping implicates two tumour suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene 12:1083-1087.
34. Wagner U, Bubendorf L, Gasser TC, Moch H, Gorog JP, Richter J, Mihatsch MJ, Waldman FM, Sauter G. 1997. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am J Pathol 151:753-759.
35. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. 1991. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 51:3807-3813.
36. Watters AD, Stacey MW, Going JJ, Grigor KM, Cooke TG, Sim E. 1998. Genetic alterations of N-acetyltransferase in transitional carcinoma of the bladder. Br J Cancer 78:141-158.
37. Wood S, Schertzer M, Drabkin H, Patterson D, Longmire JL, Deavan LL. 1992. Characterization of a human cosmid library constructed from flow-sorted chromosomes. Cytogenet Cell Genet 59:243-247.
38. Yaremko ML, Kutza C, Lyzak J, Mick R, Recant WM, Westbrook CA. 1996. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer 16:189-195.